Press releases

Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...

Yesterday saw heavy trading in Boston Scientific's (NYSE: BSX) stock, with approximately 38 million shares traded. This trading included involuntary...

Boston Scientific (NYSE: BSX) announced today it expects to record the following adjustments to its third quarter results, which it plans to report...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the PERSEUS trial, designed to evaluate the Company's...

Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court in Delaware has entered judgment against the Company...

Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22...

Boston Scientific Corporation (NYSE: BSX) announced today a decision by the United States District Court in Delaware. The case involves a patent...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America 38th Annual Investment Conference which is being held...

Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the European and Intercontinental...

Boston Scientific Corporation (NYSE: BSX) today announced one-year data from its landmark SYNTAX trial comparing percutaneous...

Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. District Court of Marshall, Texas found two patents of Medtronic, Inc....

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2008, as well as guidance for net...

Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the PROMUS™...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2008...

Boston Scientific Corporation (NYSE: BSX) today welcomed progress on a number of pieces of legislation that will help service veterans and the...

Boston Scientific Corporation - today announced that it has signed a definitive agreement to sell its investments in a portfolio of companies,...

Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by Fitch Ratings that it has revised its Rating Outlook on the Company, to...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' Annual Healthcare Conference, which is being held June 9-12...

Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the...

Boston Scientific Corporation (NYSE: BSX) today announced it has received Leadership in Energy and Environmental Design (LEED) certification from...

Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced that Boston Scientific has completed its...

Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...